Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative low-dose intravenous amiodarone for cardioversion of preoperative atrial fibrillation during mitral valve replacement
PACTR202201680255620Phase 4Completed
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms). Started Jan 2022; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on PACTR202201680255620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202201680255620.